March 06, 2015 7:45 AM ET

Capital Markets

Company Overview of De Novo Ventures

Executive Profile

F. Thomas Watkins III

Former Director, Hansen Medical, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 15 different industries.

See Board Relationships
61--

Background

Mr. F. Thomas Watkins, also known as Jay, III serves as a Director of BioParadox Inc. He has been a Member of the Board of Directors of several public companies of RITA Medical Systems Inc. He also serves on the Stanford University School of Engineering Advisory Council.He serves as an Independent Director of RefleXion Medical Inc. Mr. Watkins serves as a Director at C2 Therapeutics, Inc., Loma Vista Medical, Inc., LuMend, Pulmonx, Sierra Surgical, Ventus Medical, Inc, ...

Corporate Headquarters

14612 Big Basin Way
Saratoga, California 95070

United States

Phone: 650-329-1999
Fax: 650-329-1315

Board Members Memberships

Director
Director
Director
Director
Director
Director
Director
Director
Director
Director
Independent Director
1995-N/A
Former Director
2002-N/A
Former Director
2004-N/A
Former Director

Education

BA
Stanford University
MBA 1979
Harvard Business School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Scott William Drake Chief Executive Officer, President and Director
The Spectranetics Corporation
$596.9K
William C. Mills IIIChairman of the Board, Chief Executive Officer and Chairman of Strategy & Technology Committee
Stereotaxis Inc.
$370.9K
Michael H. Carrel Chief Executive Officer, President and Director
AtriCure, Inc.
$500.0K
George W. LeMaitre Chairman and Chief Executive Officer
LeMaitre Vascular, Inc.
$312.4K
David M. Handler Chief Executive Officer, President and Director
Corindus Vascular Robotics Inc.
$305.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact De Novo Ventures, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.